Captrust Financial Advisors Shattuck Labs, Inc. Transaction History
Captrust Financial Advisors
- $43.1 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding STTK
# of Institutions
63Shares Held
30.3MCall Options Held
36KPut Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$12.7 Million1.42% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$10.6 Million0.53% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$8.98 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$4.75 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$4.12 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $81.4M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...